PubMed:19840121
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-110 | Sentence | denotes | Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2. |
| TextSentencer_T2 | 111-303 | Sentence | denotes | BACE2 is homologous to BACE1, a beta-secretase that is involved in the amyloidogenic pathway of amyloid precursor protein (APP), and maps to the Down syndrome critical region of chromosome 21. |
| TextSentencer_T3 | 304-521 | Sentence | denotes | Alzheimer disease neuropathology is common in Down syndrome patients at relatively early ages, and it has thus been speculated that BACE2 co-overexpression with APP would promote the early neurodegenerative phenotype. |
| TextSentencer_T4 | 522-589 | Sentence | denotes | However, the in vivo function of BACE2 has not yet been elucidated. |
| TextSentencer_T5 | 590-712 | Sentence | denotes | The aim of the present work has been to analyse the impact of in vivo BACE2 overexpression using a transgenic mouse model. |
| TextSentencer_T6 | 713-840 | Sentence | denotes | Our results suggest that BACE2 is not involved in the amyloidogenic pathway, cognitive dysfunction or cholinergic degeneration. |
| TextSentencer_T7 | 841-1040 | Sentence | denotes | However, TgBACE2 animals showed increased anxiety-like behaviour along with increased numbers of noradrenergic neurones in locus coeruleus, thus suggesting an unexpected role of BACE2 overexpression. |
| T1 | 0-110 | Sentence | denotes | Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2. |
| T2 | 111-303 | Sentence | denotes | BACE2 is homologous to BACE1, a beta-secretase that is involved in the amyloidogenic pathway of amyloid precursor protein (APP), and maps to the Down syndrome critical region of chromosome 21. |
| T3 | 304-521 | Sentence | denotes | Alzheimer disease neuropathology is common in Down syndrome patients at relatively early ages, and it has thus been speculated that BACE2 co-overexpression with APP would promote the early neurodegenerative phenotype. |
| T4 | 522-589 | Sentence | denotes | However, the in vivo function of BACE2 has not yet been elucidated. |
| T5 | 590-712 | Sentence | denotes | The aim of the present work has been to analyse the impact of in vivo BACE2 overexpression using a transgenic mouse model. |
| T6 | 713-840 | Sentence | denotes | Our results suggest that BACE2 is not involved in the amyloidogenic pathway, cognitive dysfunction or cholinergic degeneration. |
| T7 | 841-1040 | Sentence | denotes | However, TgBACE2 animals showed increased anxiety-like behaviour along with increased numbers of noradrenergic neurones in locus coeruleus, thus suggesting an unexpected role of BACE2 overexpression. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 111-116 | gene:25825 | denotes | BACE2 |
| T1 | 256-285 | disease:C1860787 | denotes | Down syndrome critical region |
| T2 | 134-139 | gene:23621 | denotes | BACE1 |
| T3 | 256-285 | disease:C1860787 | denotes | Down syndrome critical region |
| T4 | 436-441 | gene:25825 | denotes | BACE2 |
| T5 | 304-321 | disease:C0002395 | denotes | Alzheimer disease |
| T6 | 1019-1024 | gene:25825 | denotes | BACE2 |
| T7 | 883-890 | disease:C0003469 | denotes | anxiety |
| R1 | T0 | T1 | associated_with | BACE2,Down syndrome critical region |
| R2 | T2 | T3 | associated_with | BACE1,Down syndrome critical region |
| R3 | T4 | T5 | associated_with | BACE2,Alzheimer disease |
| R4 | T6 | T7 | associated_with | BACE2,anxiety |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_19840121_1_0 | 207-232 | expanded | denotes | amyloid precursor protein |
| SS2_19840121_1_0 | 234-237 | abbr | denotes | APP |
| AE1_19840121_1_0 | SS1_19840121_1_0 | SS2_19840121_1_0 | abbreviatedTo | amyloid precursor protein,APP |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 19840121-1#0#5#gene25825 | 111-116 | gene25825 | denotes | BACE2 |
| 19840121-1#23#28#gene23621 | 134-139 | gene23621 | denotes | BACE1 |
| 19840121-1#96#121#gene351 | 207-232 | gene351 | denotes | amyloid precursor protein |
| 19840121-1#123#126#gene351 | 234-237 | gene351 | denotes | APP |
| 19840121-1#145#174#diseaseC1860787 | 256-285 | diseaseC1860787 | denotes | Down syndrome critical region |
| 19840121-5#25#30#gene25825 | 738-743 | gene25825 | denotes | BACE2 |
| 19840121-5#77#98#diseaseC0338656 | 790-811 | diseaseC0338656 | denotes | cognitive dysfunction |
| 19840121-6#178#183#gene25825 | 1019-1024 | gene25825 | denotes | BACE2 |
| 19840121-6#42#49#diseaseC0003467 | 883-890 | diseaseC0003467 | denotes | anxiety |
| 19840121-6#42#49#diseaseC0003469 | 883-890 | diseaseC0003469 | denotes | anxiety |
| 0#5#gene25825145#174#diseaseC1860787 | 19840121-1#0#5#gene25825 | 19840121-1#145#174#diseaseC1860787 | associated_with | BACE2,Down syndrome critical region |
| 23#28#gene23621145#174#diseaseC1860787 | 19840121-1#23#28#gene23621 | 19840121-1#145#174#diseaseC1860787 | associated_with | BACE1,Down syndrome critical region |
| 96#121#gene351145#174#diseaseC1860787 | 19840121-1#96#121#gene351 | 19840121-1#145#174#diseaseC1860787 | associated_with | amyloid precursor protein,Down syndrome critical region |
| 123#126#gene351145#174#diseaseC1860787 | 19840121-1#123#126#gene351 | 19840121-1#145#174#diseaseC1860787 | associated_with | APP,Down syndrome critical region |
| 25#30#gene2582577#98#diseaseC0338656 | 19840121-5#25#30#gene25825 | 19840121-5#77#98#diseaseC0338656 | associated_with | BACE2,cognitive dysfunction |
| 178#183#gene2582542#49#diseaseC0003467 | 19840121-6#178#183#gene25825 | 19840121-6#42#49#diseaseC0003467 | associated_with | BACE2,anxiety |
| 178#183#gene2582542#49#diseaseC0003469 | 19840121-6#178#183#gene25825 | 19840121-6#42#49#diseaseC0003469 | associated_with | BACE2,anxiety |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T340 | 1019-1024 | gene:25825 | denotes | BACE2 |
| T341 | 883-890 | disease:C0003467 | denotes | anxiety |
| R1 | T340 | T341 | associated_with | BACE2,anxiety |
| R2 | T340 | T341 | associated_with | BACE2,anxiety |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 952-960 | http://purl.obolibrary.org/obo/UBERON_2000602 | denotes | neurones |